PHILADELPHIA - Kellie Ann Jurado, PhD, has joined the Perelman School of Medicine at the University of Pennsylvania as a Presidential Assistant Professor of Microbiology. Jurado’s research examines how the immune system interacts with viral infections. Her current work investigates the abnormal immune response during Zika virus infection, including how the immune system reacts to Zika in the brain.
As a new Penn faculty member, Jurado will continue her research on Zika virus pathogenesis and how antigen-presenting cells shape T cell responses in the central nervous system. She will also start on a new line of inquiry exploring the enterovirus D68, an emerging and important viral infection that causes a polio-like disease in children. The research is expected to provide clues about how this virus attacks the body.
Jurado is the recipient of several major grants and fellowships, including the L'Oréal Women in Science Fellowship, the Charles H. Revson Senior Fellowship in Biomedical Science, and a Burroughs Wellcome Fund Postdoctoral Fellowship. She was named a 2018 "Wunderkind” by the life sciences publication STAT. She received her PhD in virology from Harvard University and served as a postdoctoral fellow at Yale University.
Jurado grew up in a small town in New Mexico where her family engages in chile pepper farming and business. Guided by her own experiences as a first-generation doctoral student who did not meet a scientist until college, Jurado gives back to the community by mentoring students at Harvard and Yale and within underserved middle and high schools in the New Haven/Bridgeport area. She has also engaged in community outreach by educating communities there about the HPV vaccine. The Hartford Courant has named her a Hometown Hero for these activities.
The Presidential Professorships are five-year term chairs, awarded by University of Pennsylvania President Amy Gutmann to outstanding scholars, whose appointments to the standing faculty are approved by the Provost and who demonstrably contribute excellence and diversity to Penn’s inclusive community.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System, which together form a $7.8 billion enterprise.
The Perelman School of Medicine has been ranked among the top medical schools in the United States for more than 20 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $425 million awarded in the 2018 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Home Care and Hospice Services, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 40,000 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2018, Penn Medicine provided more than $525 million to benefit our community.